Navigation Links
'Fecal Transplants' Show Promise for Gastrointestinal Ills

By Amanda Gardner
HealthDay Reporter

TUESDAY, Nov. 1 (HealthDay News) -- They sound disgusting, but doctors say "fecal transplants" -- once shunned by the medical establishment -- are proving useful against a range of gastrointestinal ailments, new research says.

Presenting at the American College of Gastroenterology annual meeting in Washington, D.C., researchers report that the therapy can ease severe irritable bowel syndrome and nasty bacterial infections.

Fecal microbiota transplant (FMT) involves taking feces from a donor, typically a spouse or relative though it could be anyone, after a light colonoscopy prep.

That sample is then mixed "with some saline so that it's a consistency that can be aspirated into 60 cc syringes," explained Dr. Mark Mellow, one of the researchers presenting findings at the meeting.

The patient then undergoes a routine colonoscopy during which the mixture is inserted. The idea is that this new, transplanted population of healthy flora will correct the patient's underlying problem and it does seem to work.

Some of the most encouraging research comes in the form of three studies which demonstrated the procedure's effectiveness against recalcitrant infection with the bacterium Clostridium difficile. The bug can cause disabling and even life-threatening diarrhea, nausea, vomiting and abdominal pain.

"Patients who have multiple C. difficile recurrences have a totally different population of bacteria that normal people do," said Mellow, who is medical director of the Digestive Health Center at Integris Baptist Medical Center in Oklahoma City. "The key thing is a marked decrease in diversity so, instead of having tons of different strains of microorganisms, they have many less strains and species than many people do."

In Mellow's study, 98 percent of patients with C. difficile who hadn't responded to a mean of five previous treatment courses saw rapid resolution of their symptoms -- if not with the first FMT transplant, then with a second.

The patients had been suffering for a mean of 11 months and many were ill enough to be in acute-care or skilled nursing facilities or homebound, Mellow said.

Dr. David Bernstein, chief of gastroenterology at North Shore University Hospital in Manhasset, N.Y., said: "It seems that this is potentially a phenomenal treatment for C. difficile infection, especially those that are refractory. This works and it's dramatic how quickly it works.

"C. difficile is becoming a greater problem in hospitals, and we're seeing more resistance and morbidity and mortality," he added.

Although it might seem difficult to find a volunteer, Bernstein felt that acceptance among patients would be high because "they've done so much already that has failed. They're desperate."

The transplants would not be first-line treatment for patients, however, Mellow said.

Researchers in Australia also reported success using FMT to treat ulcerative colitis and Crohn's disease in three patients. In all cases, symptoms improved within days or weeks.

Other studies being presented at the meeting found effectiveness with probiotics, live "friendly bacteria" similar to those found naturally in the gut. The idea is similar to an FMT transplant but probiotics are generally sold as dietary supplements or come in foods such as yogurt.

More information

The Mayo Clinic has more on Clostridium difficult.

SOURCES: Mark Mellow, M.D., medical director, Digestive Health Center, Integris Baptist Medical Center, Oklahoma City; David Bernstein, M.D., chief, gastroenterology, North Shore University Hospital, Manhasset, N.Y.; Oct. 31, 2011, presentations, American College of Gastroenterology annual meeting, Washington, D.C.

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Noninvasive fecal occult blood test effective screen for lower GI tract lesions
2. 1 in 6 Cellphones in Britain Contaminated With Fecal Matter
3. Internal Anthem Blue Cross/WellPoint Document: Only Patients Who Push Back Get Covered Out of State Liver Transplants
4. Los Angeles Hair Transplant Cosmetic Surgeon Corrects Bad Hair Transplants With New Hair Restoration Method
5. Kidney transplants: Expanding the pool of available organs
6. Patients with treatment-resistant CLL respond positively to stem cell transplants
7. Hispanics and Asians less likely to receive liver transplants
8. Biosynthetic Corneas Show Promise in Transplants
9. OHSU research suggests compound administered during some bone marrow transplants elevates risks
10. Kidney Transplants for Elderly Double Over Decade
11. HIV Patients Do Well After Kidney Transplants: Study
Post Your Comments:
Related Image:
'Fecal Transplants' Show Promise for Gastrointestinal Ills
(Date:11/27/2015)... ... ... The rapid speed at which Americans are aging is ... needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming more prevalent. Health ... of this equation: 80 percent of medical care occurs in the home, by ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse and ... findings on the website. Click here to read the details now. ... were treated with chemotherapy followed by EPP surgery. Among the 106 patients who relapsed, ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, from ... dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. , ... prescription medications. In doing so, it could help to prevent potential overdose situations. ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was traveling, I ... Hillside, N.J. "Many people catch diseases simply from sitting on such dirty toilet ... protected from germs." , He developed the patent-pending QUDRATECS to eliminate the need ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... AAIPharma Services Corp./Cambridge Major Laboratories, Inc. ... $15.8  Million to expand its laboratories and global ... The expansion will provide additional office space and ... of the pharmaceutical and biotechnology markets. ... up to 40,000 square feet of expanded development ...
(Date:11/25/2015)... Nov. 25, 2015  Henry Schein, Inc., the world,s ... office-based dental, medical and animal health practitioners, will unveil ... Henry Schein ConnectDental® Pavilion , which brings together ... open solutions designed to help any practice or laboratory ... for a schedule of experts appearing at the ...
Breaking Medicine Technology: